澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

DIMERIX LTD

0.320

-0.005-1.54%

成交量：32.44万

成交额：10.51万

市值：1.92亿

市盈率：-11.44

高：0.340

开：0.330

低：0.320

收：0.325

52周最高：0.785

52周最低：0.310

股本：6.00亿

流通股本：4.68亿

量比：0.42

换手率：0.07%

股息：- -

股息率：- -

每股收益(TTM):-0.028

每股收益(LYR):-0.024

净资产收益率：-594.54%

总资产收益率：-58.27%

市净率：-114.28

市盈率(LYR):-13.53

数据加载中...

总览公司新闻资讯公告

BUZZ-澳大利亚 Dimerix 公司以 48 亿美元出售资产，创下 7 个月新高

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/DXB.AU/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DXB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"DXB.AU\",,,,,undefined,":{"symbol":"DXB.AU","market":"AU","secType":"STK","nameCN":"DIMERIX LTD","latestPrice":0.32,"timestamp":1774496966191,"preClose":0.325,"halted":0,"volume":324358,"delay":0,"changeRate":-0.015384615384615398,"nameEN":"DIMERIX LTD","floatShares":467696880,"shares":600396776,"eps":-0.027967,"marketStatus":"交易中","change":-0.005,"latestTime":"03-26 14:57:21 AEDT","open":0.33,"high":0.34,"low":0.32,"amount":105077,"amplitude":0.061538,"askPrice":0.32,"askSize":74522,"bidPrice":0.315,"bidSize":92161,"shortable":3,"etf":0,"ttmEps":-0.027967,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1774501200000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.325,"openAndCloseTimeList":[[1774479600000,1774501200000]],"volumeRatio":0.418258,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"DXB.AU","preClose":0.325,"auctionPrice":0.33,"auctionVolume":3400,"auctionTime":1774479550302,"referenceTime":1774431003096,"auction":1,"marketStatus":"盘前竞价","timestamp":1774479550302}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"DXB.AU\",,,,,undefined,":{"symbol":"DXB.AU","floatShares":467696880,"roa":"-58.27%","roe":"-594.54%","lyrEps":-0.023645,"volumeRatio":0.418258,"shares":600396776,"dividePrice":0,"high":0.34,"amplitude":0.061538,"preClose":0.325,"low":0.32,"week52Low":0.31,"pbRate":"-114.28","psRate":"25.91","week52High":0.785,"institutionHeld":0,"latestPrice":0.32,"committee":0.105824,"eps":-0.027967,"divideRate":0,"volume":324358,"delay":0,"ttmEps":-0.027967,"open":0.33,"prevYearClose":0.55,"prevWeekClose":0.325,"prevMonthClose":0.475,"prevQuarterClose":0.55,"fiveDayClose":0.33,"twentyDayClose":0.455,"sixtyDayClose":0.56,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DXB.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DXB.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DXB.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2593103120","title":"BUZZ-澳大利亚 Dimerix 公司以 48 亿美元出售资产，创下 7 个月新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2593103120","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593103120?lang=zh_cn&edition=fundamental","pubTime":"2025-12-22 12:10","pubTimestamp":1766376617,"startTime":"0","endTime":"0","summary":"12月22日 - ** DimerixDXB.AX股价上涨12.5%至0.63澳元，创七个月来最高水平** 如果涨势得以保持，该股将创下六个月来的最大盘中涨幅** 生物技术公司称美国上市生物技术公司 BioMarin Pharmaceutical BMRN.O将以 48 亿美元收购  公司的美国商业许可合作伙伴 Amicus Therapeutics。** Amicus Therapeutics 是一家生物制药公司，负责向美国市场授权 DXB 的 DMX-200 药物，用于治疗罕见肾病。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nL4S3XS07W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","BK7508","IE00B7SZLL34.SGD","LU2065171402.SGD","BK7501","BMRN","LU2065171311.SGD","BK4139","DXB.AU","LU2065170008.USD","IE00B19Z3581.USD","BK7067","FOLD","IE0002270589.USD","IE00B19Z3B42.SGD","LU2065169927.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}